Cargando…
Chimeric DNA Vaccines against ErbB2(+) Carcinomas: From Mice to Humans
DNA vaccination exploits a relatively simple and flexible technique to generate an immune response against microbial and tumor-associated antigens (TAAs). Its effectiveness is enhanced by the application of an electrical shock in the area of plasmid injection (electroporation). In our studies we exp...
Autores principales: | Quaglino, Elena, Riccardo, Federica, Macagno, Marco, Bandini, Silvio, Cojoca, Rodica, Ercole, Elisabetta, Amici, Augusto, Cavallo, Federica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3759195/ https://www.ncbi.nlm.nih.gov/pubmed/24212954 http://dx.doi.org/10.3390/cancers3033225 |
Ejemplares similares
-
DNA vaccination against oncoantigens: A promise
por: Iezzi, Manuela, et al.
Publicado: (2012) -
Role of ADCC, CDC, and CDCC in Vaccine-Mediated Protection against Her2 Mammary Carcinogenesis
por: Macagno, Marco, et al.
Publicado: (2022) -
Tailoring DNA Vaccines: Designing Strategies Against HER2-Positive Cancers
por: Marchini, Cristina, et al.
Publicado: (2013) -
Inflammation and breast cancer. Inflammatory component of mammary carcinogenesis in ErbB2 transgenic mice
por: Calogero, Raffaele Adolfo, et al.
Publicado: (2007) -
Modulation of ErbB2 Blockade in ErbB2-Positive Cancers: The Role of ErbB2 Mutations and PHLDA1
por: Li, Guangyuan, et al.
Publicado: (2014)